Latest H. Lundbeck A/S Stories
EVANSTON, Ill., May 11, 2011 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.
LA JOLLA, Calif., Dec. 16, 2010 /PRNewswire/ -- Zenobia Therapeutics, Inc. (Zenobia) the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H.
MINNEAPOLIS, June 15 /PRNewswire/ -- Orasi MedicalÂ® today announced that it has entered an agreement with H.
DEERFIELD, Ill., Oct.
NEW YORK, July 10, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and its wholly-owned subsidiary, Forest Laboratories Holdings, Ltd. (collectively, "Forest"), and H.
Clinical Data, Inc. (NASDAQ:CLDA) a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that its Cogenics(R) division has entered into a Scientific Research & Development Agreement with H.
- A young chicken: also used as a pet name for children.